Dietary oxysterols are incorporated in plasma triglyceride-rich lipoproteins, increase their susceptibility to oxidation and increase aortic cholesterol concentration of rabbits

Journal of Lipid Research

Volumn 39, Issue 10, 1998, Pages 1995-2004

  Vine, D F ^a   Mamo, J C L ^a   Beilin, L J ^a   Mori, T A ^a   Croft, K D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cholesterol; Diet; Lipoprotein; Oxidation; Oxysterols

Indexed keywords

CHOLESTEROL; CHOLESTEROL DERIVATIVE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; STEROL; TRIACYLGLYCEROL;

ADOLESCENT; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; FAT INTAKE; LIPID OXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT;

ANIMALS; AORTA; CHOLESTEROL; CHOLESTEROL, DIETARY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HYDROXYCHOLESTEROLS; KETOCHOLESTEROLS; LIPID PEROXIDATION; LIPOPROTEINS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; OXIDATIVE STRESS; RABBITS; TRIGLYCERIDES;

EID: 0031713657     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Carpenter, K. L., S. E. Taylor, C. van der Veen, B. K. Williamson, J. A. Ballantine, and M. J. Mitchinson. 1995. Lipids and oxidized lipids in human atherosclerotic lesions at different stages of development. Biochim. Biophys. Acta. 1256: 141-150.
2. Carpenter, K. L., S. E. Taylor, J. A. Ballantine, B. Fussell, B. Halliwell, and M. J. Mitchinson. 1993. Lipids and oxidized lipids in human atheroma and normal aorta. Biochim. Biophys. Acta. 1167: 121-130.
3. Brooks, C. J. W., G. Steel, J. D. Gilbert, and W. A. Harland. 1971. Characterization of a new group of polar sterol esters from human atherosclerotic plaques. Atherosclerosis. 13: 223-237.
4. Carpenter, K. L., G. M. Wilkins, B. Fussel, J. A. Ballantine, S. E. Taylor, M. J. Mitchinson, and D. S. Leake. 1994. Production of oxidised lipids during modification of low-density lipoprotein by macrophages or copper. Biochem. J. 304: 625-633.
5. Witzum, J. L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
6. Mori, T. A., K. D. Croft, I. B. Puddey, and L. J. Beilin. 1996. Analysis of native and oxidized low-density lipoprotein oxysterols using gas-chromatography-mass spectrometry with selective ion monitoring. Redox Report. 21: 25-34.
7. Sevanian, A., H. N. Hodis, J. Hwang, L. L. McLeod, and H. Peterson. 1995. Characterization of endothelial cell injury by cholesterol oxidation products found in oxidized LDL. J. Lipid Res. 36: 1971-1986.
8. Brown, A. J., R. T. Dean, and W. Jessup. 1996. Free and esterified oxysterol: formation during copper-oxidation of low density lipoprotein and uptake by macrophages. J. Lipid Res. 37: 320-335.
9. van der Bovenkamp, P., T. G. Kosmeijer-Schuil, and M. B. Katan. 1988. Quantification of oxysterols in Dutch foods: egg products and mixed diets. Lipids. 23: 1079-1085.
10. Emanuel, H. A., C. A. Hassel, P. B. Addis, S. D. Bergmann, and J. H. Zavoral. 1991. Plasma cholesterol oxidation products in human subjects fed a meal rich in oxysterols. J. Food Sci. 56: 843-847.
11. Osada, K., E. Sasaki, and M. Sugano. 1994. Lymphatic absorption of oxidized cholesterol in rats. Lipids. 29: 555-559.
12. Vine, D. F., K. D. Croft, L. J. Beilin, and J. C. L. Mamo. 1997. Absorption of dietary cholesterol oxidation products and incorporation into lymph chylomicrons. Lipids. 32: 887-893.
13. Mamo, J. C. L., and J. R. Wheeler. 1994. Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as smaller macromolecules including low density lipoprotein, high density lipoprotein and albumin. Coron. Artery Dis. 5: 695-705.
14. Yu, K., and J. C. L. Mamo. 1996. Chylomicron remnant-induced foam cell formation, cytotoxicity and superoxide production in monocyte-macrophages and smooth muscle cells: possible causes for atherosclerosis. Proceedings of 22nd Australian Atherosclerosis Society. Clin. Exp. Pharm. Phys. 24: A38.
15. Proctor, S. D., and J. C. L. Mamo. 1996. Arterial fatty lesions have increased uptake of chylomicron remnants but not low-density lipoproteins. Coron. Artery. Dis. 7: 239-245.
16. Imai, H., N. T. Werthessen, C. B. Taylor, and K. T. Lee. 1976. Angiotoxicity and atherosclerosis due to contaminants of U.S.P. grade cholesterol. Arch. Pathol. Lab. Med. 100: 565-572.
17. Toda, T., D. Leszczynski and F. Kummerow. 1981. Angiotoxic effects of dietary 7-ketocholesterol in chick aorta. Paroi. Arterielle. 7: 167-176.
18. Imai, H., and H. Nakamura. 1980. Short term responses to cholesterol and oxygenated derivatives. Fed. Proc. 39: 772a.
19. Peng, S. K., B. C. Taylor, J. C. Hill, and R. J. Morin. 1985. Cholesterol oxidation derivatives and arterial endothelial damage. Atherosclerosis. 54: 121-133.
20. Taylor, C. B., S. K. Peng, N. T. Werthessen, P. Tham, and K. T. Lee. 1979. Spontaneously occurring angiotoxic derivatives of cholesterol. Am. J. Clin. Nutr. 32: 40-57.
21. Peng, S. K., B. Hu, and R. J. Morin. 1991. Angiotoxicity and atherogenicity of cholesterol oxides. J. Clin. Lab. Anal. 5: 144-152.
22. Kandutsch, A. K., and H. W. Chen. 1973. Inhibition of sterol synthesis in cultured mouse cells by 7α-hydroxycholesterol, 7β-hydroxycholesterol and 7-ketocholesterol. J. Biol. Chem. 248: 8408-8417.
23. Brown, M. S., and J. L. Goldstein. 1974. Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol. J. Biol. Chem. 249: 7306-7314.
24. Guardiola, F., R. Codony, P. B. Addis, M. Rafecas, and. J. Boatella. 1995. Biological effects of oxysterols: current status. Food Chem Toxicol.34: 193-211.
25. Verhagen, J. C., P. ter Braake, J. Teunissen, G. van Ginkel, and A. Sevanian. 1996. Physical effects of biologically formed cholesterol oxidation products on lipid membranes investigated with fluorescence depolarization spectroscopy and electron spin resonance. J. Lipid Res. 37: 1488-1502.
26. Mortimer, B. C., P. Tso, C. T. Phan, D. J. Beveridge, J. Wen, and T. G. Redgrave. 1995. Features of cholesterol structure that regulate the clearance of chylomicron-like lipid emulsions. J. Lipid Res. 36: 2038-2053.
27. Vine, D. F., J. L. Mamo, R. D. Croft, and L. J. Beilin. 1997. Absorption and in vivo kinetics of oxysterols in lymph chylomicrons. Clin. Exp. Pharmacol. Physiol. 24: A40.
28. Hodis, H. N., A. Chauhan, S. Hashimoto, D. W. Crawford, and A. Sevanian. 1992. Probucol reduces plasma and aortic wall oxysterol levels in cholesterol-fed rabbits independently of its plasma cholesterol-lowering effect. Atherosclerosis. 96: 125-134.
29. Hodis, H. N., D. W. Crawford, and A. Sevanian. 1991. Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: further evidence for the role of cholesterol oxidation in atherosclerosis. Atherosclerosis. 89: 117-126.
30. Smith, L. L. 1996. Review of progress in sterol oxidations: 1987-1995. Lipids. 31: 453-487.
31. Kim, S. K., and W. W. Nawar. 1993. Parameters influencing cholesterol oxidation. Lipids. 28: 917-922.
32. Warnick, G. R., and J. J. Albers. 1978. A comprehensive evaluation of the heparin manganese precipitation procedure for estimating HDL cholesterol. J. Lipid Res. 19: 65-73.
33. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-504.
34. Redgrave, T. G., D. C. Roberts, and C. E. West. 1975. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal. Biochem. 65: 42-49.
35. Mohr, D., and R. Stocker. 1994. Radical-mediated oxidation of isolated human very-low density lipoprotein. Arterioscler. Thromb. 14: 1186-1192.
36. Nourooz-Zadeh, J., J. Tajaddini-Saemadi, and S. P. Wolff. 1994. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal. Biochem. 220: 403-409.
37. Proudfoot, J. M., I. B. Puddey, L. J. Beilin, R. Stocker, and K. D. Croft. 1997. Unexpected dose response of copper concentration on lipoprotein oxidation in serum: discovery of a unique peroxidase-like activity of urate/albumin in the presence of high copper concentration. Free Radical Biol. Med. 23: 699-705.
38. 2-isoprostanes produced by non-cyclooxygenase free radical catalyzed mechanism. Methods Enzymol. 233: 163-174.
39. Jacobson, M. S. 1987. Cholesterol oxides in Indian ghee: possible cause of unexplained high risk of atherosclerosis in Indian immigrant populations. Lancet. II: 656-658.
40. Hulten, L. M., H. Lindmark, U. Diczfalusy, I. Björkhem, M. Ottosson, Y. Lui, G. Bondjers, and O. Wiklund. 1996. Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J. Clin. Invest. 97: 461-468.
41. Morrow, J. D., and L. J. Roberts. 1996. The isoprostanes. Biochem. Pharmacol. 51: 1-9.
42. Benga, G., A. Hodarnau, M. Ionescu, V. I. Pop, P. T. Frangopol, V. Strujan, R. P. Holmes, and F. A. Kummerow. 1983. A comparison of the effects of cholesterol and 25-hydroxycholesterol on egg yolk lecithin liposomes: spin label studies. Ann. NY Acad. Sci. 414: 140-152.
43. Rooney, M., W. Tamura-Lis, L. Lis, S. Yachnin, O. Kucuk, and J. W. Kauffman. 1986. The influence of oxygenated sterol compounds on dipalmitoylphosphatidylcholine bilayer stucture and packing. Chem. Phys. Lipids 41: 81-92.
44. Cao, J., H. M. Fales, and C. P. Schaffner. 1995. Cellular sterol accumulation stimulated by cholesterol 5α,6α-epoxide in J774 macrophages. Proc. Soc. Exp. Biol. Med. 209: 195-204.
45. Morin, R. J., and S. K. Peng. 1989. Effects of cholesterol oxidation derivatives on cholesterol esterifying and cholesteryl ester hydrolytic enzyme activity of cultured rabbit aortic smooth muscle cells. Lipids 24: 217-220.
46. Brown, M. S., S. E. Dana, and J. L. Goldstein. 1975. Cholesterol ester formation in cultured human fibroblasts, stimulation by oxygenated sterols. J. Biol. Chem. 250: 4025-4027.
47. Steinberg, D., S. Parthasarathy, T. E. Carew, J. D. Khoo, and J. L. Witztum. 1989. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
48. Mamo, J. C. L., D. Smith, K. C. Yu, A. Kawagichi, M. Harada-Shiba, T. Yamamura, and A. Yamamoto. 1998. Accumulation of chylomicron remnants in homozygous subjects with familial hypercholesterolemia. Eur. J. Clin Invest. In press.
49. Thompson, G. R. 1994. A Handbook of Hyperlipidaemia. Current Science Ltd, London.
50. Kilsdonk, E. P. C., D. W. Morel, W. J. Johnson, and G. H. Rothblat. 1995. Inhibition of cellular efflux 25-hydroxycholesterol. J. Lipid. Res. 36: 505-516.
51. Gelissen, I. C., A. J. Brown, E. L. Mander, L. Kritharides, R. T. Dean, and W. Jessup. 1996. Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketocholesterol. J. Biol. Chem. 271: 17852-17860.
52. Fielding, C. J., A. Bist, and P. E. Fielding. 1997. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc. Natl. Acad. Sci. USA. 94: 3753-3758.
53. Santillan, G., J. S. M. Sarma, G. Pawlik, A. Rackl, A. Grenieer, and R. J. Bing. 1980. Toxicity, pharmokinetics, and cholesterol-inhibitory effect of 7-ketocholesterol. Atherosclerosis. 35: 1-10.
54. Krut, L. H., J. W. Yang, G. Schonfeld, and R. E. Ostlund. 1997. The effect of oxidizing cholesterol on gastrointestinal absorption, plasma clearance, tissue distribution and processing by endothelial cells. Arterioscler. Thromb. Vasc. Biol. 17: 778-785.
55. Guyton, J. R., L. Black, and C. L. Seidal. 1990. Focal toxicity of oxysterols in vascular smooth muscle cell culture. Am. J. Pathol. 137: 425-434.